The Watson Perspective

The biotech firm enacts a 1-for-25 stock split to avoid delisting, placing its promising cancer therapy pipeline under a brighter, more critical spotlight.

Applied Optoelectronics breaks ground on a massive Texas facility, aiming to secure the domestic supply chain for the critical components powering America's AI boom.

The Estonian bank posts a 4% profit increase, balancing strong loan growth with a new five-year plan focused on digital expansion and investment services.

Following its Inc. 5000 debut, the HR tech firm adds a CRO and CMO to scale its human-centered transformation and launch a new R&D innovation lab.

Celebrating its 10th anniversary, Alleva launches InCheck, a GRC system to help behavioral health providers move from reactive compliance to a proactive strategy.

From Millennial micro-cruises to Boomer bucket lists, a new report reveals the deep generational divides reshaping the future of travel and tourism.

Sentry's new Size Analysis tool, built on its Emerge Tools acquisition, helps developers proactively shrink app size and improve the user experience.

A new book offers a critical roadmap for medical device developers facing a storm of new AI regulations, complex FDA rules, and evolving IP law.

A new NYC summit is ditching lectures for direct talks with leaders from YouTube, Wall Street, and more, reshaping career prep for high school students.

A former Texas coal mine is the epicenter of a massive project for geothermal power, ultra-fast EV charging, and one of North America's largest lithium finds.

The tech giant behind Evernote and Vimeo is launching a massive scholarship, a strategic play to secure Europe's top computer science innovators.

As AI-driven attacks surge and regulations tighten, a new partnership aims to make enterprise assets completely unreachable to hackers. Here's how.

AI genomics firm partners with two major US health systems, aiming to accelerate cancer and rare disease diagnostics for 60,000 patients annually.

As Milestone Pharma launches its novel, self-administered heart drug CARDAMYST, it hires a legal expert to navigate the high-stakes commercial rollout.

With a fresh $28M in funding, Natilus is set to commercialize its hyper-efficient blended-wing aircraft, threatening the Boeing-Airbus duopoly.

With single-use vapes banned, giants like The Vape Giant are launching advanced, high-puff kits. What does this mean for vapers, the market, and the law?

As Omada Health preps its 2025 results, all eyes are on whether its blend of tech, human coaching, and GLP-1 support can deliver sustainable profits.

A new deal pairs Inturai's AI sensing platform with a firm of elite special forces veterans, aiming to revolutionize intelligence for North American forces.

Cantor Fitzgerald launches its 15th SPAC, raising $115M. With the market rebounding, will this bet on tech and healthcare pay off for investors?

As the AI gold rush intensifies, Futurum Equities hires Rolf Bulk to lead a new semiconductor research arm, promising deeper technical insights for all investors.